Aveo Pharmaceuticals Inc (AVEO) Earnings Report Preview For Tuesday's Release
Aveo Pharmaceuticals Inc (NASDAQ:AVEO) will be releasing last fiscal quarter's results before the opening bell on February 14, 2012. We can review how Aveo Pharmaceuticals Inc has executed for investors recently.
Who They Are:
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company was founded in 2001 and is based in Cambridge, Massachusetts. Aveo Pharmaceut shares trade an average of 310,000 shares per day and has a marketcap of $620.37 Million.
52 Week High: $21.55
52 Week Low: $13.00
Float Short: 8.87%
What To Expect:
Investors will be looking to top $-0.61 per share based on the estimated mean earnings.
Currently, $-0.77 on the low end and $-0.44 per share on the high side is what market participants are anticipating in the report.
Here is a look at the fiscal year revenue for Aveo Pharmaceuticals Inc. 
Recent Stock and Valuation Performance:
For the same fiscal period year-over-year, revenue has improved to $44.68 million for 2010 vs. $20.72 million for 2009. The bottom line has falling earnings year-over-year of $-58.79 million for 2010 vs. $-44.09 million for 2009.The company's earnings before interest and taxes are falling with an EBIT year-over-year of $-56.43 million for 2010 vs. $-41.19 million for 2009.
Paid2Trade uses information believed to be correct, but is not guaranteed and is not independently checked for accuracy You may wish to use this article as a starting point of your own research with your financial planner. Seeking Alpha, Edgar Online, Zacks and Yahoo Finance provides most of the data. paid2trade.com uses the confirmed symbols from earnings.com that believed to be of the most interest.
